A rapid and sensitive LC/MS/MS assay for the quantitation of brimonidine in ocular fluids and tissues
We report here the development and validation of an LC/MS/MS method for the rapid and accurate quantitation of brimonidine in ocular tissues and fluids using brimonidine- d 4 as an internal standard (IS). Brimonidine was extracted from retina, iris/ciliary body, and vitreous humor samples with an ac...
Saved in:
Published in | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Vol. 877; no. 3; pp. 107 - 114 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
15.01.2009
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We report here the development and validation of an LC/MS/MS method for the rapid and accurate quantitation of brimonidine in ocular tissues and fluids using brimonidine-
d
4 as an internal standard (IS). Brimonidine was extracted from retina, iris/ciliary body, and vitreous humor samples with an acetonitrile:water (1:1) solution followed by sonication and vortexing. Aliquots of aqueous humor, iris/ciliary body, retina, and vitreous humor samples were diluted with acetonitrile containing IS and were separated on a reverse-phase HPLC column under isocratic conditions. Brimonidine (
m/
z transition: 292
→
212) and the internal standard (
m/
z transition: 296
→
216) were analyzed via multiple-reaction monitoring (MRM) in the positive electrospray mode on a 4000 Q TRAP
® instrument. The total analysis time for each sample was less than 2.0
min. The calibration curves for brimonidine (1–1000
ng/mL) were constructed using a linear regression with 1/
x
2 weighing. The lower limit of quantitation for brimonidine was 1.0
ng/mL for aqueous humor, 10
ng/g for iris/ciliary body, 12.5
ng/g for retina, and 1.6
ng/g for vitreous humor. Intra-day and inter-day estimates of accuracy and precision were within 15% of their nominal values indicating that the method is reliable for quantitation of brimonidine in ocular tissues and fluids. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1570-0232 1873-376X |
DOI: | 10.1016/j.jchromb.2008.11.009 |